{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:51:02Z","timestamp":1725627062283},"reference-count":12,"publisher":"Japanese Urological Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2017,7,20]]},"DOI":"10.5980\/jpnjurol.108.123","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T22:29:29Z","timestamp":1532039369000},"page":"123-127","source":"Crossref","is-referenced-by-count":1,"title":["STUDY OF NEW ORAL QUINOLONES (LEVOFLOXACIN AND SITAFLOXACIN) AS PROPHYLACTIC ANTIMICROBIAL AGENTS IN TRANSRECTAL PROSTATE NEEDLE BIOPSY"],"prefix":"10.5980","volume":"108","author":[{"given":"Hitoshi","family":"Oh-oka","sequence":"first","affiliation":[{"name":"National Hospital Organization, Kobe Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kakehi Y and Naito S; Japanese Urological Association: Complication rates of ultrasound-guided prostate biopsy: a nation-wide survey in Japan. Int J Urol, 15, 319-321, 2008.","DOI":"10.1111\/j.1442-2042.2008.02048.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Thompson PM and Talbot RW: Transrectal biopsy of the prostate and bacteraemia. Br J Surg, 67, 127-128, 1980.","DOI":"10.1002\/bjs.1800670217"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Webb NR and Woo HH: Antibiotic prophrlaxis for prostate biopsy. BJU Int, 89, 824-828, 2002.","DOI":"10.1046\/j.1464-410X.2002.02735.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Cuevas O, Oteo J, L\u00e1zaro E, Aracil B, de Abajo F, Garc\u00eda-Cobos S, Ortega A and Campos J; Spanish EARS-Net Study Group: Significant ecological impact on the progression of fluoroquinolone resistance in <i>Escherichia coli<\/i> with increased community use of moxifloxacin, levofloxacin and amoxicillin\/clavulanic acid. J Antimicrob Chemother, 66, 664-669, 2001.","DOI":"10.1093\/jac\/dkq471"},{"key":"5","doi-asserted-by":"crossref","unstructured":"7) Ozden E, Bostanci Y, Yakupoglu KY, Akdeniz E, Yilmaz AF, Tulek N and Sarikaya S: Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology, 74, 119-123, 2009.","DOI":"10.1016\/j.urology.2008.12.067"},{"key":"6","doi-asserted-by":"crossref","unstructured":"10) Yamamoto S, Shigemura K, Kiyota H, Wada K, Hayami H, Yasuda M, Takahashi S, Ishikawa K, Hamasuna R, Arakawa S and Matsumoto T; Japanese Research Group for UTI: Essential Japanese guidelines for the prevention of perioperative infections in the urological field: 2015 edition. Int J Urol, 23, 814-824, 2016.","DOI":"10.1111\/iju.13161"},{"key":"7","doi-asserted-by":"crossref","unstructured":"11) Shigemura K, Yasufuku T, Yamashita M, Arakawa S and Fujisawa M: Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study. Int J Urol, 16, 723-725, 2009.","DOI":"10.1111\/j.1442-2042.2009.02348.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"12) Anderson DL: Sitafloxacin hydrate for bacterial infections. Drugs Today (Barc), 44, 489-501, 2008.","DOI":"10.1358\/dot.2008.44.7.1219561"},{"key":"9","doi-asserted-by":"crossref","unstructured":"16) Piddock LJ: Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs, 58 (Suppl 2), 11-18, 1999.","DOI":"10.2165\/00003495-199958002-00003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"17) Heisig P: Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother, 40, 879-885, 1996.","DOI":"10.1128\/AAC.40.4.879"},{"key":"11","doi-asserted-by":"crossref","unstructured":"18) Hooper DC: Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis, 32 (Suppl 1), S9-15, 2001.","DOI":"10.1086\/319370"},{"key":"12","doi-asserted-by":"crossref","unstructured":"19) Okumura R, Hirata T, Onodera Y, Hoshino K, Otani T and Yamamoto T: Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae. J Antimicrob Chemother, 62, 98-104, 2008.","DOI":"10.1093\/jac\/dkn136"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/108\/3\/108_123\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T01:31:48Z","timestamp":1571621508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/108\/3\/108_123\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.108.123","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]}}}